Erlotinib is an anti-neoplastic medicine which is involved in the therapy of non small cell lung cancer & pancreatic cancer.
Erlotinib is a tyrosine kinase inhibitor.
The pharmacological category of Erlotinib is;
Epidermal growth factor receptor inhibitor
Tyrosine kinase inhibitor
Erlotinib cancer medicine is interceding with the production of tumor cells & reduces their spreadness in the body.
Avoid the usage of Erlotinib in case of;
Lung or breathing difficulty